|
2010
|
Invention
|
Oxa- and thiadiazoles and their use as metalloproteinase inhibitors.
Compounds formula (IA) or (... |
|
|
Invention
|
Derivatives of hydroxamic acid as metalloproteinase inhibitors.
A compound of formula (I), or an... |
|
2009
|
Invention
|
Oxa-and thiadiazoles and their use as metalloproteinase inhibitors.
Compounds formula (IA) or (I... |
|
|
Invention
|
Arylsulfonamide derivatives as c-jun-n-terminal kinases (jnk's) inhibitors.
The present inventio... |
|
2008
|
Invention
|
Use of gp130 activators in diabetic neuropathy.
The invention relates to the use a substance sig... |
|
|
Invention
|
Purification of osteopontin. The invention relates to a process for the purification of osteopont... |
|
2007
|
Invention
|
Chemokine antagonists. New CC-chemokine fusion proteins acting as dual CC-chemokine antagonists a... |
|
|
Invention
|
Methods of increasing protein expression levels.
The present invention relates to methods of inc... |
|
|
Invention
|
Csf3r polypeptides and uses thereof. The present invention relates to CSF3R polypeptide variants ... |
|
|
Invention
|
Process for globular adiponectin production. This invention relates to methods for use in industr... |
|
|
Invention
|
Jnk inhibitors for treatment of skin diseases. This invention relates to the use of a JNK inhibit... |
|
|
Invention
|
Cladribine regimen for treating multiple sclerosis. The present invention relates to the use of m... |
|
|
Invention
|
Novel heteroaryl-substituted arylaminopyridine derivatives as mek inhibitors. The invention provi... |
|
|
Invention
|
Novel arylamino n-heteraryls as mek inhibitors. The invention provides novel arylamino N-heteroar... |
|
|
Invention
|
Novel cc-chemokine antagonists. A novel CC-chemokine binding protein is isolated from the saliva ... |
|
|
Invention
|
Sulfonamide derivatives for the treatment of bacterial infections. This present invention is rela... |
|
|
Invention
|
Thiazole derivatives and use thereof.
The present invention is related to thiazole derivatives o... |
|
|
Invention
|
Thiazole derivatives and use thereof. The present invention is related to thiazole derivatives of... |
|
|
Invention
|
Novel fsh glycosylation variant d3n. FSH mutant with increased glycosylation and longer half-life... |
|
2006
|
Invention
|
Soluble il-17rc variant and uses thereof. The present invention relates to a new soluble IL-17RC ... |
|
|
Invention
|
Fsh mutants. FSH mutants with increased glycosylation and longer half-lives are described. The us... |
|
|
Invention
|
New chemokine antagonists. New CC-chemokine antagonists are provided. Compounds prepared in accor... |
|
|
Invention
|
Antiproliferative pyrimidyl, fused pyrimidyl and pyrimidyl hydrazones. The present invention is r... |
|
|
Invention
|
Erythropoietin polypeptides and uses thereof. The present invention relates to EPO polypeptides a... |
|
|
Invention
|
Compositions and methods of producing hybrid antigen binding molecules and uses thereof. This dis... |
|
|
Invention
|
Insl3/rlf polypeptides and uses thereof. The present invention relates to INSL3 polypeptides and ... |
|
|
Invention
|
N-hydroxyamide derivatives and use thereof. The present invention is related to N-hydroxyamide de... |
|
|
Invention
|
Novel cxc-chemokine antagonists. A CXC-chemokine binding protein is cloned from the salivary glan... |
|
|
Invention
|
Use of sdf-1 for the treatment and/or prevention of neurological diseases. The invention relates ... |
|
|
Invention
|
Sulfonamide derivatives and use thereof for the modulation of metalloproteinases. The present inv... |
|
|
Invention
|
Use of an immunoglobulin domain-containing cell surface recognition molecule for treating disease... |
|
2005
|
Invention
|
Use of pregnancy specific glycoprotein for maturation of oocytes.
The use of PSG for the in vitr... |
|
|
Invention
|
Methods for altering fertility.
The present invention relates to methods for enhancing fertility... |
|
|
Invention
|
Use of il-17 in the treatment of fertility-related disorders.
The present invention is directed ... |
|
|
Invention
|
Anti-lipid rafts antibodies.
The present invention relates to the discovery of antibodies able t... |
|
|
Invention
|
Method for fast substructure searching in non-enumerated chemical libraries.
The present inventi... |
|
|
Invention
|
Methods and compositions for the treatment of lipodystrophy.
The present invention is directed t... |
|
2004
|
Invention
|
Process for the production of tumor necrosis factor-binding proteins.
The invention provides met... |
|
|
Invention
|
Methods for identifying modulators of active kit tyrosine kinase receptor.
The present invention... |
|
|
Invention
|
Novel cxcl8 antagonists.
Novel antagonists of the chemokine CXCL8 (also known as Interleukin-8) ... |
|
|
Invention
|
Novel therapeutic fusion proteins.
The present invention provides novel therapeutic molecules ca... |
|
|
Invention
|
Alkynyl aryl carboxamides. 6 alkyl.
|
|
|
Invention
|
Hydrazide derivatives as prostaglandin receptors modulators. The present invention relates to hyd... |
|
|
Invention
|
Beta-amyloid inhibitors and use thereof.
Peptides and derivatives or analogs thereof are provide... |
|
|
Invention
|
Use of clusterin for the treatment and/or prevention of peripheral neurological diseases.
The in... |
|
|
Invention
|
Amylin aggregation inhibitors and use thereof.
Short peptides and derivatives or analogs thereof... |
|
|
Invention
|
Method for the identification of syntenic regions.
The identification of the syntenic regions of... |
